MarketInOut Stock Screener Log In | Sign Up
 

Apimeds Pharmaceuticals US Inc

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 06/26/2026 16:00
Apimeds Pharmaceuticals US Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNYSE
Market Capitalization13.58 mln
Float8.06 mln
Earnings Date05/29/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

1 / 100
Severely lagging

Debt / Equity

0.08
Debt-free

ROE

-68.68
Deeply negative

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Business Description

Apimeds Pharmaceuticals US Inc. is a United Arab Emirates-based company focused on building and managing bitcoin holdings as a core part of its financial strategy. It operates under the ownership of Inscobee Inc.

Key Fundamentals

EPS-2.78
ROE-68.68
ROIC-39.19
ROA-62.46
EBITDA, mln-39.53
EV / EBITDA-0.72
EV / EBIT-0.72

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio4.32
Short % of Float1.83

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -17.43% 2 / 100   
1 Month -36.62% 1 / 100   
2 Months -29.13% 4 / 100   
6 Months -60.53% 1 / 100   
1 Year -50.28% 4 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us